Michael Slifker
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 4
- Oncology 18
- Cancer Risks and Factors 4
- Co-authors
- Siddharth Balachandran (5 shared papers)Suraj Peri (9 shared papers)Eric A. Ariazi (3 shared papers)Eric A. Ross (13 shared papers)V. Craig Jordan (2 shared papers)Heather E. Cunliffe (2 shared papers)Smitha Yerrum (2 shared papers)Joan Font-Burgada (2 shared papers)
- Journals
- Cancer Research (7 papers)PLoS ONE (4 papers)Oncotarget (4 papers)International Journal of Molecular Sciences (3 papers)Cancer Prevention Research (3 papers)
- Partner nations
- United StatesSwitzerlandSweden
In The Last Decade
Michael Slifker
54 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 355
- Oncology 478
- Immunology 361
- Molecular Biology 872
- Genetics 311
Countries citing papers authored by Michael Slifker
This map shows the geographic impact of Michael Slifker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Slifker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Slifker more than expected).
Fields of papers citing papers by Michael Slifker
This network shows the impact of papers produced by Michael Slifker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Slifker. The network helps show where Michael Slifker may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Slifker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 232 | |
| 2 | 2010 | 205 | |
| 3 | 2014 | 198 | |
| 4 | 2011 | 128 | |
| 5 | 2011 | 108 | |
| 6 | 2008 | 89 | |
| 7 | 2019 | 86 | |
| 8 | 2013 | 77 | |
| 9 | 2012 | 51 | |
| 10 | 2004 | 51 | |
| 11 | 2010 | 49 | |
| 12 | 2017 | 45 | |
| 13 | 2011 | 44 | |
| 14 | 2017 | 43 | |
| 15 | 2011 | 43 | |
| 16 | 2019 | 41 | |
| 17 | 2011 | 36 | |
| 18 | 2012 | 33 | |
| 19 | 2013 | 32 | |
| 20 | 2014 | 30 |
About Michael Slifker
Michael Slifker is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers), Estrogen and related hormone effects (5 papers), interferon and immune responses (4 papers), Folate and B Vitamins Research (4 papers), Cancer Risks and Factors (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (355 citations), Oncology (478 citations), Immunology (361 citations), Molecular Biology (872 citations) and Genetics (311 citations). Michael Slifker has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include Siddharth Balachandran, Suraj Peri, Eric A. Ariazi, Eric A. Ross, V. Craig Jordan, Heather E. Cunliffe, Smitha Yerrum, Joan Font-Burgada, David Rossell and Trey Ideker. Their work appears in journals such as Cancer Research, PLoS ONE, Oncotarget, International Journal of Molecular Sciences and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.